methyl 5-aminolevulinate has been researched along with Actinic Keratosis in 142 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (5.63) | 29.6817 |
| 2010's | 126 (88.73) | 24.3611 |
| 2020's | 8 (5.63) | 2.80 |
| Authors | Studies |
|---|---|
| Festa-Neto, C; Grinblat, B; Haedersdal, M; Szeimies, RM; Torezan, L | 1 |
| Bernal-Masferrer, L; Cerro-Muñoz, P; García-Gil, MF; Gilaberte, Y; Gracia-Cazaña, T; Navarro-Bielsa, A | 1 |
| Durães, SMB; Issa, MCA; Pereira, AD; Pires, M; Pires, MTF | 1 |
| Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Merks, I; Mosterd, K; Nelemans, PJ | 1 |
| Berking, C; Heppt, MV; Steeb, T | 2 |
| Ali, FR; Raza, SA | 1 |
| Belmontesi, M | 1 |
| Feldman, SR; Heron, CE | 1 |
| Ahmady, S; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ | 1 |
| Cassano, N; Fai, C; Fai, D; Vena, GA | 2 |
| Jemec, GBE; Yazdanyar, S; Zarchi, K | 1 |
| Gonzalez, H; Haedersdal, M; Halldin, C; Sandberg, C; Sørensen, SS; Togsverd-Bo, K; Wennberg, AM; Wulf, HC | 1 |
| Gerber, PA; Karrer, S; Kohl, E; Koller, M; Philipp-Dormston, WG; Prager, W; Szeimies, RM; Zeman, F | 1 |
| Cantisani, C; Eibenschutz, L; Fargnoli, MC; Gaastra, MTW; Hunger, RE; Ibbotson, SH; Kerrouche, N; Medina, S; Pérez-Garcia, B; Rostain, G; Venema, AW | 1 |
| Galimberti, GN | 1 |
| Festa-Neto, C; Grinblat, B; Haedersdal, M; Szeimies, RM; Torezan, L; Valente, N | 1 |
| Abbade, LPF; Ferreira, ER; Miola, AC; Miot, HA; Schmitt, JV | 1 |
| Philipp-Dormston, WG | 1 |
| Bieliauskiene, G; Heerfordt, IM; Wulf, HC | 1 |
| Dirschka, T; Novak, B; Rybarski, M; Schmitz, L | 1 |
| Braathen, LR; Morton, CA | 1 |
| Abbade, LPF; Ferreira, ER; Lima, TRR; Miola, AC; Miot, HA; Schmitt, JV | 1 |
| Apalla, Z; Ioannides, D; Kirmanidou, E; Lallas, A; Lazaridou, E; Sideris, N; Sotiriou, E; Vakirlis, E; Vrani, F | 1 |
| Arisi, M; Calzavara-Pinton, P; Hamon, PA; Tanova, NT; Zane, C | 1 |
| Bancalari, E; Bernia, E; Calomarde, L; Diago, A; Guillén, C; Kindem, S; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Serra-Guillén, I | 1 |
| Aschoff, R; Botella-Estrada, R; Dirschka, T; Dominicus, R; Ekanayake-Bohlig, S; Herrera-Ceballos, E; Hunfeld, A; Kremser, M; Lübbert, H; Puig, S; Schmitz, B | 1 |
| Bay, C; Haedersdal, M; Karmisholt, KE; Phothong, W; Togsverd-Bo, K; Wenande, E | 1 |
| Aguayo-Carreras, P; Cuenca-Barrales, C; Ruiz-Villaverde, R; Sáenz-Guirado, S | 1 |
| Johansen, UB; Wiegell, SR; Wulf, HC | 1 |
| Bottoniτ, U; Calvieri, S; Cantisani, C; Cantoresi, F; Didona, D; Losco, L; Mercuri, SR; Moliterni, E; Paolino, G; Scarnò, M; Tallarico, M | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Grönroos, M; Hagman, J; Neittaanmäki, N; Räsänen, JE; Rissanen, P; Salmivuori, M; Snellman, E; Ylianttila, L; Ylitalo, L | 1 |
| Béhal, H; Deleporte, P; Duhamel, A; Kerob, D; Lecomte, F; Maire, C; Mordon, S; Mortier, L; Thecua, E; Vicentini, C; Vignion-Dewalle, AS | 1 |
| Ianhez, M | 1 |
| Mei, X; Wang, L; Zhang, R; Zhong, S | 1 |
| Aguilera, J; Alegre-Sánchez, A; Fernández-Guarino, M; Fonda-Pascual, P; Gilaberte-Calzada, Y; González-Morales, ML; Harto-Castaño, A; Jaen-Olasolo, P; Moreno-Arrones, OM; Pérez-García, B; Pindado-Ortega, C | 1 |
| Aschoff, RAG; Chavda, R; Dominicus, R; Gauglitz, GG; Karrer, S; Kerrouche, N; Krähn-Senftleben, G; Szeimies, RM; Zarzour, A | 1 |
| Kim, HJ; Seo, JW; Song, KH | 1 |
| Bierman, DF; Coakley, BJ; Haedersdal, M; Serowka Lane, KL; Shive, ML; Wiegell, SR; Zachary, CB | 1 |
| Calzavara-Pinton, P; Szeimies, RM | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Kouloubis, N; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Steijlen, PM; van Pelt, HPA | 1 |
| Almagro-Sánchez, M; Gilaberte, Y; Gracia-Cazaña, T; Linares, DP; Malinis, AJG | 1 |
| Fargnoli, MC; Gutiérrez García-Rodrigo, C; Pellegrini, C; Piccioni, A; Tambone, S | 1 |
| Heerfordt, IM; Wulf, HC | 1 |
| Fu, C; Kuang, BH; Qin, L; Wang, BC; Zeng, XY | 1 |
| Borik, L; Brunner, PM; Geusau, A; Mildner, M; Müllegger, R; Petzelbauer, P; Tzaneva, S | 1 |
| Arbustini, E; Borroni, RG; Brazzelli, V; Carugno, A; Rivetti, N | 1 |
| Babilas, P | 1 |
| Enzmann, H; Hoppe, U; Kiely, P; O'Dea, G; Pignatti, F; Salmon, P; Salmonson, T; Straube, M; Tzogani, K | 1 |
| Gupta, AK; Paquet, M | 1 |
| Chaves, Y; Festa-Neto, C; Niwa, A; Sanches, JA; Szeimies, RM; Torezan, L | 1 |
| Kloser, A; Lee, PK | 1 |
| Grönroos, M; Neittaanmäki-Perttu, N; Pölönen, I; Ranki, A; Saksela, O; Snellman, E; Tani, T | 1 |
| Barge, J; Kasraee, B; Piffaretti, F; Salomon, D; van den Bergh, H; Wagnières, G; Zellweger, M | 1 |
| Basset-Seguin, N | 1 |
| Banzhaf, CA; Jemec, GB; Mogensen, M; Themstrup, L | 1 |
| Jeon, SY; Kim, KH; Ko, DY; Song, KH | 1 |
| Calzavara-Pinton, PG; Facchinetti, E; Rossi, MT; Specchia, C; Zane, C | 1 |
| Bardazzi, F; Burtica, EC; Giordano, F; Loi, C; Magnano, M; Patrizi, A | 1 |
| Bosc, C; Foley, P; Hewitt, D; Kerob, D; Kerrouche, N; Murrell, DF; Rubel, DM; See, JA; Shumack, S; Spelman, L; Wulf, HC | 1 |
| Tolley, K; Vegter, S | 1 |
| Erlendsson, AM; Hædersdal, M; Lei, U; Philipsen, PA; Skov, L; Taudorf, EH; Togsverd-Bo, K; Wulf, HC | 1 |
| Petersen, B; Wiegell, SR; Wulf, HC | 2 |
| Grönroos, M; Karppinen, TT; Neittaanmäki-Perttu, N; Snellman, E; Tani, TT | 2 |
| Bodet, D; García-Patos, V; Gemigniani, F; González-Llavona, B | 1 |
| Armstrong, AW; Eisen, DB; Patel, G | 1 |
| Lui, H | 1 |
| Graf, B; Gruber, M; Hansen, E; Heinlin, J; Horner, C; Karrer, S; Kerscher, C; Klein, A; Koller, M; Landthaler, M; Szeimies, RM; Werner, A; Zeman, F | 1 |
| Wiegell, SR | 1 |
| Baharlou, S; Basset-Seguin, N; Braathen, LR; Gilaberte, Y; Hunger, RE; Morton, CA; Piaserico, S; Sidoroff, A; Sotiriou, E; Szeimies, RM; Wulf, HC | 1 |
| Fargnoli, MC; Neri, L; Pellegrini, C; Peris, K; Piccioni, A; Tambone, S | 2 |
| Gruber-Wackernagel, A; Reginato, E; Wolf, P | 1 |
| Jang, YH; Jung, SE; Kang, HY; Kim, YC; Lee, ES; Song, HS | 1 |
| Fernández-Peñas, P; Foley, P; Hewitt, D; Murrell, DF; Rubel, DM; Salmon, R; See, JA; Shumack, S; Spelman, L | 1 |
| Aguilar, M; Almagro, M; Correia, O; Gilaberte, Y; Guillén, C; Harto, A; Pérez-García, B; Pérez-Pérez, L; Redondo, P; Sánchez-Carpintero, I; Serra-Guillén, C; Valladares, LM | 1 |
| Amerio, P; Auriemma, M; Capo, A; Di Nicola, M; Gonzalez, S; Piaserico, S | 1 |
| Egekvist, H; Erlendsson, AM; Haedersdal, M; Lorentzen, HF; Philipsen, PA; Stausbøl-Grøn, B; Stender, IM | 1 |
| Alkemade, HA; Gerritsen, MJ; Groenewoud, H; Grutters, JP; Maessen-Visch, MB; Seubring, I; van de Kerkhof, PC; van der Wilt, GJ; van Doorn, R; van Rijsingen, MC | 1 |
| Adamski, H; Basset-Seguin, N; Dreno, B; Gerritsen, MJ; Gilaberte, Y; Girard, C; Kelleners-Smeets, N; Kerrouche, N; Lacour, JP; Leclerc, S; Perez-Garcia, B; Redondo, P; Serra-Guillen, C; Synnerstad, I; Szeimies, RM; Tarstedt, M; Tsianakas, A; Ulrich, C; Venema, AW; Von Felbert, V | 1 |
| Ibbotson, SH; Kulyk, O; Moseley, H; Samuel, ID; Valentine, RM | 1 |
| Bosselmann, I; Enk, AH; Fink, C; Gholam, P | 1 |
| Kelleners-Smeets, NW; Kessels, JP; Krekels, GA; Mosterd, K; Nelemans, PJ; Ostertag, JU | 1 |
| Bjerring, P; Cartier, H; Le Pillouer-Prost, A; Philipp-Dormston, WG; Sanclemente, G; Szeimies, RM; Torezan, L; Tretti Clementoni, M | 1 |
| Berneburg, M | 1 |
| Berking, C; Dirschka, T; Gerber, PA; Hunger, RE; Karrer, S; Lonsdorf, AS; Petering, H; Philipp-Dormston, WG; Radakovic, S; Szeimies, RM; Ulrich, C | 1 |
| Fai, C; Fai, D; Genovese, G; Mavilia, L; Mercuri, SR | 1 |
| Grönroos, M; Neittaanmäki-Perttu, N; Snellman, E; Tani, T | 1 |
| Adamski, H; Basset-Séguin, N; Beaulieu, P; Dreno, B; Girard, C; Lacour, JP; Riboulet, JL | 1 |
| Abdulkareem, AA; Hamdoon, Z; Hopper, C; Jerjes, W | 1 |
| Amann, PM; Baron, JM; Gerber, PA; Huth, L; Huth, S; Leverkus, M; Marquardt, Y | 1 |
| Anzalone, A; Cardone, M; Carlesimo, M; De Vita, G; Di Nunno, D; Fortuna, MC; Garelli, V; Mari, E; Pranteda, G; Rossi, A | 1 |
| Calzavara-Pinton, P; Pacou, M; Szeimies, RM; Zane, C | 1 |
| Mühlstädt, M | 1 |
| Karrer, S; Kohl, E; Koller, M; Landthaler, M; Popp, C; Szeimies, RM; Unger, P; Zeman, F | 1 |
| Arisi, M; Calzavara-Pinton, I; Calzavara-Pinton, P; Moggio, E; Zane, C | 1 |
| Arisi, M; Calzavara-Pinton, P; Fabiano, A; Zane, C | 1 |
| Heerfordt, IM; Mikkelsen, CS; Nissen, CV; Wiegell, SR; Wulf, HC | 2 |
| Bowling, J; Campbell, S; Ibbotson, S; Kownacki, S; Morton, CA; Sivaramakrishnan, M; Stones, R; Valentine, R | 1 |
| Gerritsen, MP; Groenewoud, JMM; Seubring, I | 1 |
| Hambly, RA; Lenane, P; Mansoor, N; Moloney, FJ; Quinlan, C; Ralph, N; Shah, Z | 1 |
| Fernández-Guarino, M; Harto, A; Jaén, P; Marquet, A; Pérez-García, B; Sánchez-Ronco, M | 1 |
| Berking, C; Bhatia, AC; Davis, SA; Fesq, H; Frambach, Y; Klövekorn, W; Matheson, RT; Reifenberger, J; Szeimies, RM; Thaçi, D | 1 |
| Braathen, LR; Fritsch, C; Frølich, KW; Gardlo, K; Morken, T; Paredes, BE; Ros, AM; Saksela, O; Solér, AM; Warloe, T | 1 |
| Bower, CB; Downs, AM; Oliver, DA; Stone, CA | 1 |
| Eriksen, P; Haedersdal, M; Wiegell, SR; Wulf, HC | 1 |
| Downs, A; Muston, D; Rives, V | 1 |
| Arpaia, N; Cassano, N; Fai, D; Romano, I; Vena, GA; Vestita, M | 1 |
| Babilas, P; Karrer, S; Landthaler, M; Schreml, S; Steinbauer, JM; Szeimies, RM; Zeman, F | 1 |
| Gerritsen, RM; Kleinpenning, MM; van de Kerkhof, PC | 1 |
| Abuzahra, F; Braathen, LR; Hoff-Lesch, S; Hoffmann, G; Merk, HF; Renn, CN; von Felbert, V | 1 |
| Fernández-Guarino, M; Harto, A; Jaén, P | 1 |
| Campbell, S; Curnow, A; Tyrrell, J | 1 |
| Denk, K; Enk, A; Gholam, P; Hartmann, M; Sehr, T | 1 |
| Campbell, SM; Curnow, A; Tyrrell, JS | 1 |
| Chimenti, S; Colombo, GL; Di Matteo, S; Fargnoli, MC; Frascione, P; Peris, K; Silipo, V | 1 |
| Wilson, EC | 1 |
| Botella-Estrada, R; Guillen, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillen, C | 1 |
| Boiy, A; de Witte, PA; Roelandts, R | 1 |
| Andersen, BL; Berne, B; Brocks, KM; Fabricius, S; Haedersdal, M; Heydenreich, J; Jemec, GB; Kroon, S; Mogensen, M; Mørk, C; Philipsen, PA; Sandberg, C; Stender, IM; Wiegell, SR; Wulf, HC | 1 |
| Campbell, SM; Curnow, A; Morton, C; Tyrrell, JS | 1 |
| Bagazgoitia, L; Cuevas Santos, J; Jaén, P; Juarranz, A | 1 |
| Salmon, R; Tran, DT | 1 |
| Berking, C; Borrosch, F; Brüning, H; Deichmann, M; Dirschka, T; Dominicus, R; Foguet, M; Gröne, D; Helwig, C; Hofbauer, G; Hönigsmann, H; Hübinger, F; Jenne, L; Karl, L; Klövekorn, W; Krähn-Senftleben, G; Lehmann, P; Lübbert, H; Mensing, H; Moers-Carpi, M; Oster-Schmidt, C; Radny, P; Reich, K; Reinhold, U; Schmitz, B; Sebastian, M; Simon, M; Szeimies, RM; Tanner, M; Wernicke-Panten, K; Wolf, P | 1 |
| Fabricius, S; Heydenreich, J; Wiegell, SR; Wulf, HC | 1 |
| Baltás, E; Gaál, M; Gyulai, R; Kemény, L; Ocsai, H; Oláh, J; Otrosinka, S | 1 |
| Baron, ED; Lee, Y | 1 |
| Hauschild, A | 1 |
| Botella-Estrada, R; Guillén, C; Hueso, L; Llombart, B; Messeguer, F; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V | 1 |
| Andersen, BL; Berne, B; Brocks, KM; Fabricius, S; Gniadecka, M; Heydenreich, J; Hædersdal, M; Ibler, KS; Jemec, GB; Kroon, S; Mørk, C; Philipsen, PA; Sandberg, C; Stender, IM; Wiegell, SR; Wulf, HC | 1 |
| Babilas, P; Festa-Neto, C; Karrer, S; Kohl, E; Niwa, A; Schreml, S; Szeimies, RM; Torezan, L; Unger, P; Valente, N | 1 |
| Anderson, RR; Haak, CS; Hædersdal, M; Hædesdal, M; Thaysen-Petersen, D; Togsverd-Bo, K; Wulf, HC | 1 |
| Morton, CA | 1 |
| Baldursson, BT; Bäumler, W; Enk, CD; Fabricius, S; Heydenreich, J; Rosso, S; Wiegell, SR; Wulf, HC | 1 |
| Allen, J; Blake, E; Curnow, A; Shore, A; Thorn, C | 1 |
| Bissonnette, R; Bolduc, C; Maari, C; Nigen, S | 1 |
| Berking, C; Borrosch, F; Brüning, H; Deichmann, M; Dirschka, T; Dominicus, R; Foguet, M; Gröne, D; Hahn, S; Hofbauer, G; Hönigsmann, H; Hübinger, F; Jenne, L; Karl, L; Klövekorn, W; Krähn-Senftleben, G; Lehmann, P; Lübbert, H; Mensing, H; Moers-Carpi, M; Oster-Schmidt, C; Pabst, G; Radny, P; Reich, K; Reinhold, U; Schmitz, B; Sebastian, M; Simon, M; Szeimies, RM; Tanner, M; Voss, D; Wernicke-Panten, K; Wolf, P | 1 |
17 review(s) available for methyl 5-aminolevulinate and Actinic Keratosis
| Article | Year |
|---|---|
Photodynamic therapy for aesthetic-cosmetic indications.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Light; Pain; Photochemotherapy; Photosensitizing Agents; Rejuvenation; Skin Aging; Time Factors; Treatment Outcome | 2018 |
Daylight photodynamic therapy for field cancerization: lessons from molecular biology.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Humans; Keratosis, Actinic; Light; Pain; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2018 |
Daylight Photodynamic Therapy for Actinic Keratoses.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Dermatologic Agents; Drug Therapy, Combination; Emulsions; Humans; Keratosis, Actinic; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Skin; Sunlight; Sunscreening Agents; Treatment Outcome | 2018 |
Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Severity of Illness Index; Sunlight | 2019 |
Efficacy and safety of photodynamic therapy with amino-5-laevulinate nanoemulsion versus methyl-5-aminolaevulinate for actinic keratosis: A meta-analysis.
Topics: Aminolevulinic Acid; Emulsions; Humans; Keratosis, Actinic; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic | 2019 |
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Current methods for photodynamic therapy in the US: comparison of MAL/PDT and ALA/PDT.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Disease Progression; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome; United States | 2013 |
[PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology].
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Clinical Trials as Topic; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Precancerous Conditions; Skin Diseases; Skin Neoplasms | 2013 |
A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe.
Topics: Aminolevulinic Acid; Clinical Trials as Topic; Europe; Face; Humans; Keratosis, Actinic; Photochemotherapy; Scalp; Treatment Outcome | 2014 |
Efficacy of photodynamic therapy vs other interventions in randomized clinical trials for the treatment of actinic keratoses: a systematic review and meta-analysis.
Topics: Aminolevulinic Acid; Cryotherapy; Keratosis, Actinic; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2014 |
Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus.
Topics: Administration, Topical; Aminolevulinic Acid; Consensus; Europe; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Societies, Medical | 2015 |
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia.
Topics: Aminolevulinic Acid; Australia; Consensus; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Severity of Illness Index; Sunlight; Treatment Outcome | 2016 |
Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group.
Topics: Administration, Topical; Aminolevulinic Acid; Consensus; Europe; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents | 2016 |
Daylight PDT with MAL - current data and practical recommendations of an expert panel.
Topics: Aminolevulinic Acid; Evidence-Based Medicine; Germany; Humans; Keratosis, Actinic; Light; Pain; Photochemotherapy; Photosensitizing Agents; Practice Guidelines as Topic; Treatment Outcome | 2015 |
Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis.
Topics: Adjuvants, Immunologic; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Photochemotherapy; Randomized Controlled Trials as Topic; Sunlight | 2016 |
[Studies of methyl aminolevulinate photodynamic therapy for actinic keratosis].
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents | 2010 |
Photodynamic therapy: current evidence and applications in dermatology.
Topics: Acne Vulgaris; Aminolevulinic Acid; Bowen's Disease; Candidiasis; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Leishmaniasis, Cutaneous; Lymphoma, T-Cell, Cutaneous; Photochemotherapy; Photosensitizing Agents; Psoriasis; Skin Neoplasms; Tinea Capitis; Warts | 2011 |
65 trial(s) available for methyl 5-aminolevulinate and Actinic Keratosis
| Article | Year |
|---|---|
A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses | 2021 |
Laser-assisted MAL-PDT associated with acoustic pressure wave ultrasound with short incubation time for field cancerization treatment: A left-right comparison.
Topics: Adult; Aged; Aminolevulinic Acid; Combined Modality Therapy; Elasticity Imaging Techniques; Female; Forearm; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Ultrasonic Waves | 2019 |
A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherla
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2020 |
The Effect of Four Approaches to Treat Actinic Keratosis on the Health-Related QOL, as Assessed by the Skindex-29 and Actinic Keratosis QOL.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Patient Reported Outcome Measures; Photochemotherapy; Quality of Life; Skin Cream; Surveys and Questionnaires; Treatment Outcome | 2021 |
Pain during topical photodynamic therapy - comparing methyl aminolevulinate (Metvix
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Photochemotherapy; Photosensitizing Agents | 2017 |
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Topics: Aged; Aminolevulinic Acid; Drug Eruptions; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2018 |
Daylight photodynamic therapy versus cryosurgery for the treatment and prophylaxis of actinic keratoses of the face - protocol of a multicenter, prospective, randomized, controlled, two-armed study.
Topics: Adult; Aminolevulinic Acid; Cryosurgery; Female; Humans; Intention to Treat Analysis; Keratosis, Actinic; Male; Photochemotherapy; Research Design; Single-Blind Method; Sunlight | 2017 |
Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
Topics: Adult; Aged; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Remission Induction; Scalp; Sunlight | 2018 |
A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Drug Therapy, Combination; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin; Treatment Outcome | 2018 |
Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Scalp | 2018 |
Effectiveness and safety of 0·5% colchicine cream vs. photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratosis and skin field cancerization of the forearms: a randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Atrophy; Biopsy; Carcinoma, Squamous Cell; Colchicine; Disease Progression; Female; Forearm; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin; Skin Cream; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2018 |
Short incubation fractional CO
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Absorption; Skin Neoplasms; Time Factors | 2019 |
A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Erythema; Face; Female; Humans; Keratosis, Actinic; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp; Skin; Treatment Outcome; Visual Analog Scale | 2018 |
A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Female; Gels; Germany; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Prognosis; Severity of Illness Index; Skin Cream; Spain; Statistics, Nonparametric; Treatment Outcome | 2019 |
Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Aminolevulinic Acid; Brimonidine Tartrate; Clobetasol; Denmark; Erythema; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Time Factors; Treatment Outcome | 2019 |
Sequential methyl-aminolevulinate daylight photodynamic therapy and diclofenac plus hyaluronic acid gel treatment for multiple actinic keratosis evaluation.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Quality of Life; Rome; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 2018 |
5-aminolaevulinic acid nanoemulsion is more effective than methyl-5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis: a nonsponsored randomized double-blind multicentre trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Cost-Benefit Analysis; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2019 |
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight p
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Forehead; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Pain, Procedural; Patient Reported Outcome Measures; Photochemotherapy; Photosensitizing Agents; Scalp; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2019 |
A comparison of the efficacy of ablative fractional laser-assisted photodynamic therapy according to ablative depth for actinic keratosis: A single-blinded, randomized, comparative, prospective study.
Topics: Ablation Techniques; Aminolevulinic Acid; Humans; Keratosis, Actinic; Lasers, Solid-State; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Single-Blind Method; Treatment Outcome | 2019 |
Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Follow-Up Studies; Gels; Humans; Imiquimod; Intention to Treat Analysis; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Proportional Hazards Models; Scalp Dermatoses; Single-Blind Method; Skin Cream; Treatment Outcome | 2019 |
Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Administration Schedule; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Scalp; Sunlight | 2019 |
Daylight photodynamic therapy of actinic keratosis without curettage is as effective as with curettage: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Sunlight; Treatment Outcome | 2019 |
Photodynamic therapy 'to go' - a strengths, weaknesses, opportunities and threats analysis.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Photochemotherapy; Proof of Concept Study | 2019 |
Peptidase inhibitor 3 and chemokine ligand 27 may serve as biomarkers for actinic keratoses in organ transplant recipients.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Biomarkers; Chemokine CCL27; Elafin; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Prospective Studies; Reference Values; RNA, Messenger; Severity of Illness Index; Transplant Recipients; Treatment Outcome | 2019 |
The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: summary of the scientific assessment of the Committee for Medicinal Products for Human Us
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Face; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp; Survival Rate; Treatment Outcome; Young Adult | 2014 |
A pilot split-face study comparing conventional methyl aminolevulinate-photodynamic therapy (PDT) with microneedling-assisted PDT on actinically damaged skin.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2013 |
Detecting field cancerization using a hyperspectral imaging system.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Asymptomatic Diseases; Biopsy; Feasibility Studies; Female; Humans; Image Interpretation, Computer-Assisted; Keratosis, Actinic; Male; Narrow Band Imaging; Photography; Photosensitizing Agents; Pilot Projects; Skin | 2013 |
Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Tomography, Optical Coherence | 2014 |
Fractional erbium: YAG laser-assisted photodynamic therapy for facial actinic keratoses: a randomized, comparative, prospective study.
Topics: Aged; Aminolevulinic Acid; Asian People; Face; Female; Humans; Keratosis, Actinic; Lasers, Solid-State; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Recurrence; Republic of Korea; Severity of Illness Index; Time Factors; Treatment Outcome | 2014 |
A randomized clinical trial of photodynamic therapy with methyl aminolaevulinate vs. diclofenac 3% plus hyaluronic acid gel for the treatment of multiple actinic keratoses of the face and scalp.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cost-Benefit Analysis; Diclofenac; Drug Combinations; Facial Dermatoses; Female; Gels; Humans; Hyaluronic Acid; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Combination of ablative fractional laser and daylight-mediated photodynamic therapy for actinic keratosis in organ transplant recipients - a randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Combined Modality Therapy; Female; Humans; Keratosis, Actinic; Laser Therapy; Male; Middle Aged; Pain; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Transplant Recipients; Treatment Outcome | 2015 |
Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Clobetasol; Erythema; Facial Dermatoses; Female; Fluoroscopy; Glucocorticoids; Humans; Keratosis, Actinic; Male; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2014 |
Daylight photodynamic therapy for actinic keratoses: a randomized double-blinded nonsponsored prospective study comparing 5-aminolaevulinic acid nanoemulsion (BF-200) with methyl-5-aminolaevulinate.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp Dermatoses; Treatment Outcome | 2014 |
Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Analgesia; Analgesics, Opioid; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cold Temperature; Dipyrone; Facial Dermatoses; Forehead; Hemodynamics; Humans; Injections, Intravenous; Keratosis, Actinic; Male; Middle Aged; Nerve Block; Ophthalmic Nerve; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pirinitramide; Quality of Life; Scalp; Scalp Dermatoses; Trochlear Nerve | 2015 |
Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Female; Humans; Keratosis, Actinic; Male; Ointments; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Treatment Outcome | 2016 |
Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carbon Dioxide; Female; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Absorption; Time Factors; Treatment Outcome | 2015 |
Polypodium leucotomos supplementation in the treatment of scalp actinic keratosis: could it improve the efficacy of photodynamic therapy?
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Phytotherapy; Plant Extracts; Polypodium; Recurrence; Scalp Dermatoses | 2015 |
Daylight photodynamic therapy with methyl aminolevulinate cream is effective and nearly painless in treating actinic keratoses: a randomised, investigator-blinded, controlled, phase III study throughout Europe.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Europe; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Severity of Illness Index; Single-Blind Method; Skin Cream; Sunlight; Treatment Outcome | 2015 |
Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Optical Imaging; Photosensitizing Agents; Point-of-Care Systems; Protoporphyrins; Skin Neoplasms | 2015 |
Laser-mediated Photodynamic Therapy: An Alternative Treatment for Actinic Keratosis?
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Lasers, Dye; Low-Level Light Therapy; Male; Middle Aged; Pain; Pain Measurement; Patient Preference; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dermatologic Agents; Diterpenes; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Remission Induction; Scalp Dermatoses; Sunlight; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2016 |
Long-term Outcome of Daylight Photodynamic Therapy with Amino-5-laevulinate Nanoemulsion vs. Methyl-5-aminolaevulinate for Actinic Keratoses.
Topics: Aminolevulinic Acid; Female; Head; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2016 |
Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Erythema; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Ointments; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp Dermatoses; Treatment Outcome | 2016 |
Photodynamic therapy using intense pulsed light for treating actinic keratoses and photoaged skin of the dorsal hands: a randomized placebo-controlled study.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Esthetics; Female; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Aging; Treatment Outcome | 2017 |
A randomized split-face clinical trial analyzing daylight photodynamic therapy with methyl aminolaevulinate vs ingenol mebutate gel for the treatment of multiple actinic keratoses of the face and the scalp.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Administration Schedule; Facial Dermatoses; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Preference; Photochemotherapy; Scalp Dermatoses; Treatment Outcome | 2016 |
A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Face; Facial Dermatoses; Female; Follow-Up Studies; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Remission Induction; Retrospective Studies; Scalp; Scalp Dermatoses; Skin; Treatment Outcome | 2016 |
Increased protoporphyrin IX accumulation does not improve the effect of photodynamic therapy for actinic keratosis: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Drug Eruptions; Erythema; Female; Fluorescence; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Protoporphyrins | 2017 |
Pretreatment with 5-Fluorouracil Cream Enhances the Efficacy of Daylight-mediated Photodynamic Therapy for Actinic Keratosis.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Combined Modality Therapy; Denmark; Female; Fluorouracil; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Remission Induction; Skin; Sunlight; Time Factors; Treatment Outcome; Wound Healing | 2017 |
Comparison of "Lesion-by-Lesion" and Field Photodynamic Therapy in the Prevention of Actinic Keratoses: A Randomized, Split-Face, Single-Blind Pilot Study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Single-Blind Method | 2016 |
Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2009 |
Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cosmetics; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Recurrence; Treatment Outcome | 2009 |
Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heliotherapy; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Statistics as Topic; Treatment Outcome | 2009 |
Photodynamic therapy of multiple actinic keratoses: reduced pain through use of visible light plus water-filtered infrared A compared with light from light-emitting diodes.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Double-Blind Method; Female; Filtration; Humans; Infrared Rays; Keratosis, Actinic; Lasers, Semiconductor; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Water | 2010 |
A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminolevulinic Acid; Aminoquinolines; Child; Child, Preschool; Facial Dermatoses; Female; Humans; Imiquimod; Infant; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Young Adult | 2011 |
A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Facial Dermatoses; Female; Heliotherapy; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photosensitizing Agents; Scalp Dermatoses; Time Factors | 2011 |
Comparison of protoporphyrin IX accumulation and destruction during methylaminolevulinate photodynamic therapy of skin tumours located at acral and nonacral sites.
Topics: Adult; Aged; Aminolevulinic Acid; Analysis of Variance; Extremities; Facial Dermatoses; Female; Fluorescence; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Protoporphyrins; Scalp Dermatoses; Skin Neoplasms | 2011 |
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; Young Adult | 2012 |
Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
Topics: Adolescent; Adult; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Light; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Time Factors | 2011 |
A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Female; Humans; Imiquimod; Immunocompetence; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Treatment Outcome | 2012 |
Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Dose-Response Relationship, Radiation; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Radiation Dosage; Scalp Dermatoses; Sunlight; Sunscreening Agents; Treatment Outcome | 2012 |
Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Clinical Protocols; Facial Neoplasms; Female; Humans; Immunohistochemistry; Keratosis, Actinic; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Skin Aging | 2012 |
Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Humans; Keratosis, Actinic; Laser Therapy; Lasers, Gas; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Skin Aging; Treatment Outcome | 2012 |
Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy.
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Oxygen; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Pressure; Protoporphyrins; Skin Neoplasms | 2013 |
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Keratosis, Actinic; Long-Term Care; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Recurrence; Treatment Outcome | 2013 |
60 other study(ies) available for methyl 5-aminolevulinate and Actinic Keratosis
| Article | Year |
|---|---|
Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp; Sunlight; Treatment Outcome | 2022 |
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy | 2020 |
Comparison of efficacy of field treatments for actinic keratoses.
Topics: Adult; Aminolevulinic Acid; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Scalp Dermatoses | 2020 |
Sequential Treatment of Actinic Keratosis and Photoaging by Daylight PDT and Injectable NASHA Gel as Skin Booster.
Topics: Aged; Aminolevulinic Acid; Face; Female; Gels; Humans; Hyaluronic Acid; Injections, Subcutaneous; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Severity of Illness Index; Skin Aging; Sunlight; Treatment Outcome | 2020 |
Ingenol Mebutate and the Treatment of Actinic Keratosis.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2021 |
Long-term follow-up assessment of daylight photodynamic therapy with methyl aminolevulinate in patients with actinic keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2017 |
Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Attitude of Health Personnel; Europe; Facial Dermatoses; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Physicians; Prospective Studies; Scalp Dermatoses; Sunlight; Surveys and Questionnaires | 2018 |
Daylight photodynamic therapy with methyl aminolevulinate for the treatment of actinic keratoses of the forearms.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Forearm; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Sunlight | 2019 |
Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol.
Topics: Aminolevulinic Acid; Clinical Protocols; Colchicine; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Cream | 2018 |
Evaluation of the costs of topical treatments for actinic keratosis based on lesion response and the affected area.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Europe; Humans; Italy; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2018 |
Efficacy and safety of daylight photodynamic therapy after tailored pretreatment with ablative fractional laser or microdermabrasion: a randomized, side-by-side, single-blind trial in patients with actinic keratosis and large-area field cancerization.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinogenesis; Combined Modality Therapy; Dermabrasion; Dose Fractionation, Radiation; Female; Humans; Keratosis, Actinic; Laser Therapy; Light; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin; Treatment Outcome | 2019 |
Day light photodynamic therapy with BF-200 ALA: A case series.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Sunlight | 2018 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Skin field cancerization - an in vivo model to prevent nonmelanoma skin cancer: expanding the alternatives for treatment.
Topics: Aminolevulinic Acid; Colchicine; Forearm; Humans; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms | 2018 |
Low-level light-assisted photodynamic therapy using a wearable cap-like device for the treatment of actinic keratosis of the scalp.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Combined Modality Therapy; Female; Humans; Keratosis, Actinic; Low-Level Light Therapy; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Scalp Dermatoses; Severity of Illness Index | 2019 |
Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Germany; Humans; Keratosis, Actinic; Male; Patient Reported Outcome Measures; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Self Care; Sunlight; Surveys and Questionnaires; Treatment Outcome | 2019 |
Use of 5-Aminolevulinic Acid and Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses.
Topics: Aminolevulinic Acid; Facial Dermatoses; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Sunlight; Treatment Outcome | 2019 |
A randomized, double-blind trial comparing 5-aminolaevulinic acid nanoemulsion with methyl 5-aminolaevulinate in daylight photodynamic therapy for actinic keratosis.
Topics: Aminolevulinic Acid; Double-Blind Method; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents | 2019 |
Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Drug Therapy, Combination; Female; Humans; Keratosis, Actinic; Male; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Sunlight | 2019 |
Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer.
Topics: Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Blood Pressure; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Hypertension; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Risk Factors; Skin Neoplasms | 2013 |
Long-term follow-up of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.
Topics: Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents | 2013 |
Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy.
Topics: Aged; Aminolevulinic Acid; Fluorescence; Humans; Keratosis, Actinic; Middle Aged; Pain; Pain Measurement; Photobleaching; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Treatment Outcome | 2013 |
Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Risk Factors; Skin Neoplasms | 2015 |
Peripheral facial palsy after topical photodynamic therapy for facial actinic keratoses.
Topics: Aminolevulinic Acid; Bell Palsy; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Cream | 2014 |
Photodynamic therapy for actinic keratoses: aren't we there yet?
Topics: Aminolevulinic Acid; Cryotherapy; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents | 2014 |
Update on photodynamic treatment for actinic keratosis.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Photosensitizing Agents | 2015 |
Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Humans; Italy; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Recurrence; Scalp Dermatoses; Skin Cream; Sunlight; Sunscreening Agents; Temperature | 2015 |
Methyl aminolevulinate photodynamic therapy for actinic keratosis does not affect peripheral regulatory T-cell level or function.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; T-Lymphocytes, Regulatory | 2015 |
Spanish-Portuguese consensus statement on use of daylight-mediated photodynamic therapy with methyl aminolevulinate in the treatment of actinic keratosis.
Topics: Aminolevulinic Acid; Clinical Protocols; Humans; Keratosis, Actinic; Patient Selection; Photochemotherapy; Photosensitizing Agents; Portugal; Spain; Sunlight; Sunscreening Agents; Temperature; Treatment Outcome | 2015 |
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cross-Sectional Studies; Cryotherapy; Denmark; Dermatology; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Outpatient Clinics, Hospital; Photochemotherapy; Photosensitizing Agents; Practice Patterns, Physicians'; Private Practice; Sex Factors; Skin Neoplasms | 2016 |
Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Dermatologic Agents; Drug Costs; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Netherlands; Patient Preference; Photochemotherapy; Photosensitizing Agents; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
Retrospective analysis evaluating the effect of a keratolytic and physical pretreatment with salicylic acid, urea and curettage on the efficacy and safety of photodynamic therapy of actinic keratoses with methylaminolaevulinate.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Salicylic Acid; Urea | 2016 |
[Not Available].
Topics: Aminolevulinic Acid; Evidence-Based Medicine; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2015 |
[Procedure for daylight methyl aminolevulinate photodynamic therapy to treat actinic keratoses].
Topics: Aminolevulinic Acid; Clinical Protocols; Facial Dermatoses; Humans; Keratosis, Actinic; Pain; Patient Education as Topic; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Skin Cream; Sunlight; Treatment Outcome | 2016 |
Photodynamic therapy in the management of actinic keratosis: Retrospective evaluation of outcome.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Neoplasms, Squamous Cell; Photochemotherapy; Photosensitizing Agents; Recurrence; Retrospective Studies; Risk Factors | 2017 |
Ablative non-sequential fractional ultrapulsed CO
Topics: Aminolevulinic Acid; Cell Culture Techniques; Cell Line, Tumor; Drug Evaluation, Preclinical; Humans; Keratosis, Actinic; Laser Therapy; Lasers, Gas; Photochemotherapy; Photosensitizing Agents | 2016 |
Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization.
Topics: Aged; Aminolevulinic Acid; Carcinoma, Squamous Cell; Dermoscopy; Humans; Keratosis, Actinic; Middle Aged; Photosensitizing Agents; Skin Neoplasms | 2016 |
Ingenol Mebutate vs. Daylight Photodynamic Therapy in a Kidney Transplant Recipient.
Topics: Aged; Aminolevulinic Acid; Antineoplastic Agents; Carcinogenesis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Face; Humans; Keratosis, Actinic; Kidney Transplantation; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Transplant Recipients | 2016 |
Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp.
Topics: Aminolevulinic Acid; Facial Dermatoses; Follow-Up Studies; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Recurrence; Scalp Dermatoses; Sunlight; Treatment Outcome | 2017 |
A consensus on the use of daylight photodynamic therapy in the UK.
Topics: Aminolevulinic Acid; Consensus; Humans; Keratosis, Actinic; Light; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; United Kingdom | 2017 |
Factors predicting pain and effect of oral analgesia in topical photodynamic therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Analgesics; Bowen's Disease; Carcinoma, Basal Cell; Extremities; Female; Head and Neck Neoplasms; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Risk Factors; Sex Factors; Skin Neoplasms; Torso | 2017 |
[Retrospective, descriptive, observational study of treatment of multiple actinic keratoses with topical methyl aminolevulinate and red light: results in clinical practice and correlation with fluorescence imaging].
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Fluorescence; Hand Dermatoses; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photography; Photosensitizing Agents; Retrospective Studies; Scalp Dermatoses; Treatment Outcome | 2008 |
Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation.
Topics: Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents | 2009 |
An economic evaluation of topical treatments for actinic keratosis.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Cost-Benefit Analysis; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; United Kingdom | 2009 |
Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Pain; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Salvage Therapy; Skin Neoplasms; Treatment Outcome | 2009 |
Topical photodynamic therapy with porphyrin precursors--assessment of treatment-associated pain in a retrospective study.
Topics: Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Sex Factors | 2009 |
The clinical efficacy of topical methyl-aminolevulinate photodynamic therapy in moderate to severe actinic keratoses of the face and scalp.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Carcinoma, Squamous Cell; Cohort Studies; Facial Dermatoses; Female; Follow-Up Studies; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Patient Compliance; Photochemotherapy; Precancerous Conditions; Probability; Risk Assessment; Scalp Dermatoses; Severity of Illness Index; Skin Neoplasms; Treatment Failure; Treatment Outcome | 2010 |
Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT.
Topics: Aged; Aminolevulinic Acid; Dose-Response Relationship, Drug; Fluorescence; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Reproducibility of Results; Skin; Skin Neoplasms | 2010 |
Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Cosmetic Techniques; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Nerve Endings; Pain; Pain Measurement; Photochemotherapy; Protoporphyrins; Retrospective Studies; Sex Characteristics; Treatment Outcome | 2010 |
The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photobleaching; Photochemotherapy; Photosensitizing Agents; Precancerous Conditions; Skin Diseases; Skin Neoplasms; Treatment Outcome | 2010 |
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Decision Trees; Delivery of Health Care; Diclofenac; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic | 2010 |
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Cost-Benefit Analysis; Data Interpretation, Statistical; Decision Trees; Humans; Imiquimod; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Quality-Adjusted Life Years; United Kingdom | 2010 |
Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Topics: Administration, Topical; Aminolevulinic Acid; Animals; Anthracenes; Antineoplastic Agents; Disease Models, Animal; Female; Keratosis, Actinic; Mice; Mice, Hairless; Microscopy, Fluorescence; Perylene; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Ultraviolet Rays | 2011 |
Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Biomarkers, Tumor; Biopsy; Cyclin D; Female; Humans; Keratosis, Actinic; Ki-67 Antigen; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Tumor Suppressor Protein p53 | 2011 |
Field treatment of facial and scalp actinic keratoses with photodynamic therapy: survey of patient perceptions of treatment satisfaction and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Humans; Keratosis, Actinic; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses | 2011 |
Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Analysis of Variance; Bowen's Disease; Carcinoma, Basal Cell; Extremities; Female; Head; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Photosensitizing Agents; Skin Neoplasms; Torso | 2012 |
Photodynamic therapy for actinic keratoses: procedure matters?
Topics: Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy | 2012 |
Can photodynamic therapy reverse the signs of photoageing and field cancerization?
Topics: Aminolevulinic Acid; Facial Neoplasms; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Skin Aging | 2012 |
Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
Topics: Aminolevulinic Acid; Dose-Response Relationship, Radiation; Europe; Geography, Medical; Humans; Israel; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Radiometry; Residence Characteristics; Seasons; Skin Neoplasms; Sunlight; Temperature; Ultraviolet Rays; Weather | 2013 |
Short incubation photodynamic therapy with methylaminolevulinate and no occlusion for the treatment of actinic keratoses.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents | 2012 |